Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...

Denmark's Zealand Pharma and German partner Boehringer Ingelheim have won the U.S. Food and Drug Administration's ...

Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma ...

Find out how this could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations.

Boehringer Ingelheim and Circle Pharma have entered a new research partnership and licence agreement to develop a new ...

Boehringer Ingelheim, in partnership with the WHO Foundation [an organisation set up to support the World Health Organization ...

Boehringer Ingelheim has taken an option on a family ... broad activity against the symptoms of the disorder. The German pharma company is paying a signing fee of €25 million for the portfolio ...

Bayer and Boehringer Ingelheim both had new data on their HER2 ... Another oral HER2 agent – Spectrum Pharma's poziotinib – was rejected by the FDA as a second-line treatment for NSCLC with ...

At the end of the episode, before the credits roll a pop up appears on the screen sharing a dedication to Martin Maynard. So who was Martin Maynard? Here's what you need to know about the man the ...